Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07119489 · ClinicalTrials.gov registry record · NA
A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
A NA study of Smoking Behavior, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 2
- Study locations
NCT07119489 is a NA study of Smoking Behavior that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 16 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07119489, a NA study of Smoking Behavior, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to learn more about how Dialectical Behavior Therapy - Skills Training can help patients with cancer who smoke cigarettes cut down on or stop their smoking.
Conditions Studied
Interventions
- BEHAVIORAL Dialectical Behavior Therapy -Skill Training brief intervention
Study Locations (2)
North Carolina
- Atrium Health Levine Cancer - Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2026-02-11 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07119489
The ClinicalTrials.gov registry entry for NCT07119489 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Behavior appearing as the primary indexed condition, and to 1 intervention - of which Dialectical Behavior Therapy -Skill Training brief intervention is the first listed.
NCT07119489 reports 2 study locations spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07119489 about?
NCT07119489 is a clinical study titled "A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial". The purpose of this research study is to learn more about how Dialectical Behavior Therapy - Skills Training can help patients with cancer who smoke cigarettes cut down on or stop their smoking.
What is the current status of trial NCT07119489?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2026-02-11. Estimated completion is 2026-11.
What conditions does trial NCT07119489 study?
This clinical trial studies the following conditions: Smoking Behavior.
What interventions are being tested in trial NCT07119489?
The interventions under investigation include: Dialectical Behavior Therapy -Skill Training brief intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07119489?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07119489 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.